Context Therapeutics Inc. CNTX
0.35
(0.02)
(5.41%)
as of 25 Sep
- Market cap
- $34.1M
- P/E
- 0.0×
Follow CNTX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
5.81 | 8.96 | 8.52 | 13.10 |
+8 more quarters Free account |
Net Debt/EBITDA |
2.87 | 5.84 | 4.78 | 7.25 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.48 | 1.32 | 0.69 | 0.68 | |
Capex/Depreciation |
(2.79) | (7.94) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.07) | (0.12) | (0.09) | (0.07) | |
Cash per Share |
0.45 | 0.57 | 0.69 | 0.81 | |
Shareholders Equity per Share |
0.40 | 0.55 | 0.64 | 0.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.40 | 0.55 | 0.64 | 0.77 | |
Free Cash Flow |
(7.04) | (11.47) | (8.94) | (6.58) | |
Working Capital |
37.93 | 51.98 | 60.33 | 73.02 | |
Capital Expenditures |
(0.02) | (0.04) | 0.00 | 0.00 | |
Net Current Asset Value |
37.86 | 51.86 | 60.33 | 73.00 | |
| Other line items | |||||
Quick Ratio |
5.45 | 8.35 | 8.23 | 12.75 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.07) | (0.12) | (0.09) | (0.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.84 | 1.73 | 1.99 | 1.87 | |
Average Assets |
66.64 | 75.91 | 83.31 | 82.78 | |
Average Common Equity |
60.36 | 71.59 | 77.87 | 78.52 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates